The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback